Filing Details

Accession Number:
0001085146-25-000947
Form Type:
13G Filing
Publication Date:
2025-02-09 19:00:00
Filed By:
Westfield Capital Management Company, L.P.
Company:
Ascendis Pharma A/S
Filing Date:
2025-02-10
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Westfield Capital Management Company, L.P. 0 4,075,214 9.18%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G


 
Westfield Capital Management Company, L.P.
 
Signature:Brandi McMahon
Name/Title:Vice President, Deputy Chief Compliance Officer
Date:02/07/2025